Skip to content

Providing Unique Support for Health (PUSH) Study

Identifying and Engaging Urban HIV Infected and Uninfected YBMSM in Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03194477
Enrollment
631
Registered
2017-06-21
Start date
2017-08-01
Completion date
2022-09-06
Last updated
2023-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV-1-infection

Keywords

HIV young Black men who have sex with men substance use

Brief summary

Project Narrative This 5-city proposal seeks to address HIV disparities among young (ages 15-24) Black and/or Latinx men who have sex with men (YBLMSM) and transgender women (YBLTW) in a multilevel intervention to identify, engage and retain, high-risk HIV-uninfected and HIV-infected urban YBMSM/TW in the HIV prevention and treatment cascade. The mobile-enhanced engagement intervention (MEI) is driven by the expressed and self-determined needs of each HIV infected and uninfected participant and includes care navigation, engagement, treatment and adherence. MEI also includes a supplemental Screening, Brief Intervention, and Referral for Treatment (SBIRT), to support YBLMSM/TW who face barriers accessing substance use treatment. By building upon existing case management services and flexibility to be adapted across ages and maturity and for prevention services, this intervention has the ability to transform networks, HIV and prevention care in YBLMSM/TW in cities with very high primary and secondary HIV transmission.

Detailed description

Project Summary The U.S. National HIV/AIDS Strategy 2020 calls for increasing access to care and improving outcomes of people living with HIV and targeting biomedical prevention efforts (including access to pre-exposure prophylaxis \[PrEP\]) where HIV is most heavily concentrated. Baltimore, MD; Washington, DC; Philadelphia, PA (BWP); and Tampa and St. Petersburg, FL. are disproportionately burdened by high rates of new cases of HIV infection, with disproportionate rates in young Black and/or Latinx men who have sex with men (YBLMSM) and transgender women (YBLTW) aged 15-24. High incidence underscores the need for increased identification, linkage and initiation in HIV and preventive care for YBLMSM. Grants focused on high rates directly address NIH research priorities to reduce health disparities in the incidence of HIV, in antiretroviral therapy (ART) outcomes or in high HIV prevalent or high-risk areas. This innovative proposal seeks to test, treat and retain YBLMSM/TW living in BWP along the prevention and treatment continuum using the following aims: Aim 1. Identify and recruit young (ages 15-24) Black and/or Latinx men who have sex with men (YBLMSM) in 3 urban cities who are (1) HIV-infected, not virally suppressed; and (2) high-risk HIV-uninfected YBLMSM, including gender variant and questioning men, using respondent driven sampling (RDS) with targeted seed identification. Assigned female sex at birth participants may be eligible to screen and participate in this aim to assist in recruiting YBLMSM/TW; Aim 2. Compare the efficacy of two study arms (mobile-enhanced engagement intervention (MEI) vs. standard of care (SOC)) to achieve sustained retention (measured by ≥ 4 follow up visits per 18-months) and engagement in HIV care (measured by durable viral suppression (HIV VL \< 20 copies/ml) and substance treatment among 240 HIV-infected YBLMSM who are not virally suppressed and recruited from RDS; and Aim 3. Modify and implement mobile-enhanced intervention for 225 high-risk HIV-uninfected YBLMSM, recruited from RDS to promote linkage, retention and engagement of pre-exposure prophylaxis (PrEP) and substance treatment uptake over 18-months, comparing younger (15-19) and older (20-24) participants.

Interventions

BEHAVIORALMobile-enhanced Engagement Intervention

Mobile phone based enhanced case management intervention for HIV positive & HIV negative young Black men who have sex with men.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Johns Hopkins Bloomberg School of Public Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Caregiver)

Masking description

Care providers and investigators will not know which patients are randomized to intervention or control.

Intervention model description

Mobile-enhanced engagement interventions (MEI) to support 1) HIV viral suppression among HIV-positive, not virally suppressed participants; 2) HIV-PrEP uptake among high-risk HIV-negative participants; and 3) engagement in substance abuse treatment for HIV-positive and HIV-negative participants.

Eligibility

Sex/Gender
ALL
Age
15 Years to 24 Years
Healthy volunteers
Yes

Inclusion criteria

Natal Male Inclusion Criteria: * Assigned male at birth * 15-24 years old * English speaking * Black/African American * Hispanic/Latino ethnicity * HIV positive, viral load of 20 or greater * HIV negative, at high risk of HIV acquisition * Sex with another male within last 12-months * No plans to move outside of the research catchment area in next 18-months * Able and willing to provide informed consent * Not currently taking pre-exposure prophylaxis (PrEP) * Not currently enrolled or planning to enrolled in an HIV vaccine trial * Not currently enrolled or planning to enroll in an HIV adherence intervention Natal Male

Exclusion criteria

* Birth-identified female * under age 15 * Over age 24 * Non-English speaking * No sex with another male in prior 12-months * Not Black/African American or Hispanic identified * HIV-positive, virally suppressed * HIV-negative, not at high risk of HIV acquisition * Unable or unwilling to provide consent for study participation * Unable or unwilling to return for study visits * Unwilling to provide an oral, blood or urine specimen for testing * Currently taking pre-exposure prophylaxis (PrEP) * Active or previous participation in an HIV vaccine trial * Current participation in an adherence intervention (unless proof in the non-intervention arm) * plan to relocate out of Baltimore, Washington DC, or Philadelphia in next 18- months Natal Female Inclusion Criteria: * Assigned female sex at birth * English speaking * 15-24 years old * Have friends who are gay or bisexual males or transgender females Natal Female

Design outcomes

Primary

MeasureTime frameDescription
HIV Viral Suppression18-monthsDurable viral suppression (VL \< 20 copies/ml)
PrEP Uptake18-monthsEngagement in HIV pre-exposure prophylaxis (PrEP) services

Secondary

MeasureTime frameDescription
Engagement in substance abuse treatment services6-monthsDefined as at least two substance abuse treatment visits

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026